We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$3.89B
AUM Growth
+$2.3B
Cap. Flow
+$1.81B
Cap. Flow %
46.45%
Top 10 Hldgs %
13.13%
Holding
1,688
New
594
Increased
357
Reduced
244
Closed
486

Sector Composition

Rank Sector Weight
1 Technology 19.6%
2 Consumer Discretionary 13.23%
3 Financials 10.89%
4 Industrials 10.19%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIT
1651
DELISTED
Fitbit, Inc. Class A common stock
FIT
-205,000
Closed -$1.36M
PE
1652
DELISTED
PARSLEY ENERGY INC
PE
-82,300
Closed -$472K
TCO
1653
DELISTED
Taubman Centers Inc.
TCO
-9,900
Closed -$415K
MYOK
1654
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-17,087
Closed -$801K
BITA
1655
DELISTED
Bitauto Holdings Limited
BITA
-11,200
Closed -$116K
LVGO
1656
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-8,810
Closed -$251K
AXAS
1657
DELISTED
Abraxas Petroleum Corp
AXAS
-1,110
Closed -$3K
CCXX.U
1658
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
-3,000,000
Closed -$30M
GMO
1659
DELISTED
General Moly, Inc.
GMO
-35,800
Closed -$6K
SMRT
1660
DELISTED
Stein Mart Inc
SMRT
-48,500
Closed -$22K
DNR
1661
DELISTED
Denbury Resources, Inc.
DNR
-38,600
Closed -$7K
PTLA
1662
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-13,114
Closed -$94K
STML
1663
DELISTED
Stemline Therapeutics, Inc.
STML
-960,088
Closed -$4.65M
CSFL
1664
DELISTED
CenterState Bank Corporation Common Stock
CSFL
-12,664
Closed -$218K
UNT
1665
DELISTED
UNIT Corporation
UNT
-16,700
Closed -$4K
JCP
1666
DELISTED
J.C. Penney Company, Inc.
JCP
-39,100
Closed -$14K
AGN
1667
DELISTED
Allergan plc
AGN
-208,797
Closed -$37M
TSG
1668
DELISTED
The Stars Group Inc.
TSG
-10,000
Closed -$204K
MLNX
1669
DELISTED
Mellanox Technologies, Ltd.
MLNX
-5,600
Closed -$679K
RARX
1670
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-7,264
Closed -$349K
KEM
1671
DELISTED
KEMET Corporation
KEM
-20,600
Closed -$498K
FLY
1672
DELISTED
Fly Leasing Limited
FLY
-15,400
Closed -$108K
IBTX
1673
DELISTED
Independent Bank Group, Inc.
IBTX
-37,291
Closed -$883K
VSTO
1674
DELISTED
Vista Outdoor Inc.
VSTO
-14,100
Closed -$124K
FM
1675
DELISTED
iShares Frontier and Select EM ETF
FM
-99,081
Closed -$2.12M

Similar funds

Schonfeld Strategic Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Schonfeld Strategic Advisors held 1,688 positions worth $3.89B, up 145% from $1.59B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.81B of net new capital in Q2 2020, opening 594 new positions and adding to 357 existing holdings. Its largest new stake was Claritev Corp: 75,000 shares worth $32.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JD.com, an estimated $29.9M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2020 buy was Claritev Corp: 75,000 shares worth $32.4M.
  • Schonfeld Strategic Advisors added most to TC Energy in Q2 2020, an estimated $113M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2020 reduction was JD.com, cutting an estimated $29.9M.
  • Schonfeld Strategic Advisors fully exited Allergan plc in Q2 2020, selling an estimated $37M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $3.89B portfolio in Q2 2020.
  • Schonfeld Strategic Advisors opened 594 new positions and closed 486 in Q2 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 145% quarter-over-quarter to $3.89B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.